ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Dermavant raises $200m to support tapinarof launch pharmaceutical-technology
June 10, 2021Dermavant Sciences has signed a $160m revenue interest purchase and sale agreement for tapinarof with Marathon Asset Management, NovaQuest Capital Management and a third unnamed institutional investor in the US. -
NovaQuest Private Equity Acquires CoreRx contractpharma
January 20, 2021?NovaQuest Private Equity has acquired CoreRx, a global contract development and manufacturing organization (CDMO).
Pharma Sources Insight January 2025
